Back to Journals » Risk Management and Healthcare Policy » Volume 17

Original Research

Recombinant Human Follicle-Stimulating Hormone in Controlled Ovarian Hyperstimulation with Assisted Reproductive Technology in China: A Cost-Effectiveness Analysis

       
Total article views   HTML views PDF downloads Totals
1,440 Dovepress* 1,420+ 24 1,444
PubMed Central* 20 14 34
Totals 1,440 38 1,478
*Since 27 May 2024

View citations on PubMed and Google Scholar